Targeting the epigenome for treatment of cancer

E-J Geutjes1, P K Bajpe, R Bernards

  • 1Division of Molecular Carcinogenesis, Centre for Biomedical Genetics and Cancer Genomics Centre, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Oncogene
|December 6, 2011
PubMed

Insights

Enzymes regulating cell epigenetics are often altered in cancer. Targeting these epigenetic regulators offers a new strategy for developing selective cancer therapies.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Cancer genome studies reveal frequent deregulation of epigenetic gene regulation enzymes.
  • Epigenetic modifications play a crucial role in cellular function and are often dysregulated in cancerous cells.

Purpose of the Study:

  • To describe enzymes controlling the cell's epigenetic state.
  • To explain how these enzymes are affected in cancer.
  • To explore the therapeutic potential of targeting these enzymes in cancer treatment.

Main Methods:

  • Review of cancer genome analyses.
  • Description of epigenetic regulatory enzymes.
  • Analysis of enzyme alterations in cancer.
  • Exploration of targeted therapeutic strategies.

Main Results:

  • Epigenetic regulatory enzymes are frequently deregulated in various cancers.
  • Understanding these deregulations provides insights into cancer development.
  • Targeting specific epigenetic enzymes can lead to novel cancer therapies.

Conclusions:

  • Epigenetic deregulation is a hallmark of cancer.
  • Selective therapies targeting epigenetic enzymes represent a promising new approach to cancer treatment.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...